Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yuwen Zhou
CONTACT
Lead
Meng Qiu
With
This is a single-center, open-label, exploratory phase II clinical trial designed to investigate the efficacy and safety of SHR-3821 in combination with fruquintinib for the treatment of metastatic colorectal cancer.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
